inSoma is pleased to welcome Thalia Charles as its Head of Regulatory Affairs. In this role, Ms. Charles will support the advancement of inSoma’s regenerative reconstruction platform, Fractomer™, into clinical evaluation for its potential as a safe and natural option for patients opting for reconstruction. She brings 20 years’ experience steering medical devices through agency oversight to market, and deep expertise in the reconstruction and augmentation regulatory environment. Ms. Charles joins inSoma from Establishment Labs where she served as Senior Director of Global Regulatory Affairs. Prior to Establishment Labs, she served as Director of Regulatory Affairs for TransMedics, Inc. Across her career, she has successfully navigated the regulatory landscape for products including donor organ preservation systems, cancer screening products, and coagulopathy testing. She received her Master’s in developmental psychobiology from Indiana University–Bloomington and her B.S. in psychology from Brown University.
News
February 28th, 2024
January 4th, 2024
Dr. Juliana Blum Joins inSoma Board of Directors
November 1st, 2023